Comments Submitted: Draft Guidance, Key Information and Facilitating Understanding in Informed Consent; FDA-2022-D-2997 Public Comment Submitted on: April 30, 2024 Submitted to: U.S. Food and Drug Administration; HFA-305 Download the PDF 2024-04-30 KI ICF FDA-2022-D-2997
